Navigation Links
Breast Cancer Treatment Is Reduced to One Week
Date:1/29/2008

Chicago-Area Community Hospital to Offer New Clinical Study to Breast

Cancer Patients

EVERGREEN PARK, Ill., Jan. 29 /PRNewswire/ -- Little Company of Mary Hospital and Health Care Centers in Evergreen Park, Illinois, near Chicago (http://www.PursuingPainFreeCancer.org/breastcancer), has announced it will offer a new clinical study by Xoft using electronic brachytherapy for the treatment of early stage breast cancer. The study involves the delivery of a safer form of radiation to breast cancer patients that will reduce the average treatment time from seven weeks to just one week.

Axxent Electronic Brachytherapy System uses a small electronic, low-energy X-ray source that delivers controlled radiation treatment directly to the targeted area. It is similar to another known procedure called Mammosite, but uses a different type of radiation. The Electronic Brachytherapy System uses a balloon-like device, which is implanted at the targeted area. Twice a day for five days, the balloon is expanded and a miniature X-ray tube is inserted.

Little Company of Mary is the first community hospital in Illinois to offer the study, joining only nine other sites in the country that offer the treatment. "I am proud to bring this new technology to Little Company of Mary and offer the women in Chicago's Southwest community a new and safer form of radiation therapy for the treatment of breast cancer," said radiation oncologist Dr. Adam Dickler. Dr. Dickler was the study's principal investigator when it was first offered in Illinois prior to arriving at Little Company of Mary in October.

Dr. Dickler says the major benefit for patients is the largely reduced treatment time, which would help many women receive the treatment they need without having to undergo therapy for seven weeks. A key component that sets this therapy apart is that electronic br
'/>"/>

SOURCE Little Company of Mary Hospital and Health Care Centers
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Peregrine Pharmaceuticals Opens Enrollment in Phase II Clinical Trial of Bavituximab in Patients with Advanced Breast Cancer
2. Peregrine Pharmaceuticals Receives Approval to Conduct a Second Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
3. Kosan Initiates Phase 2 Trial of Alvespimycin, Second-Generation Hsp90 Inhibitor, in HER2-Positive Metastatic Breast Cancer
4. Orion Genomics Announces the Discovery of Novel Breast Cancer Biomarkers
5. Video: New Results From One of the Worlds Largest Breast Cancer Trials Herald Hope for Thousands of Women
6. US Oncology Research Network Presents Clinical Studies at San Antonio Breast Cancer Symposium
7. New Drug Combination is Able to Eradicate Breast Metastases in Mice
8. PTC Therapeutics Presents Encouraging Phase 1 Results of its Novel VEGF Inhibitor, PTC299, at 30th Annual San Antonio Breast Cancer Symposium
9. Multiple Studies Presented at San Antonio Breast Cancer Symposium Reinforce Clinical Utility of Oncotype DX(R)
10. Pilot Study Opens the Door for Avastin Use in Curative Setting for Women With Breast Cancer
11. Anastrozole Confirmed Superior in Breast Cancer Prevention

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009).../ -- Volcano Corporation (Nasdaq: VOLC ), a leade...ducts for the diagnosis and treatment of coronary ...will be participating in the Third Annual Canaccor...0. ,, The presentation by Scott Huennekens, pre...1 p.m., Pacific Standard Time (4 p.m., Eastern Sta...
(Date:11/9/2009)...tCall/ -- Cardiac Science Corporation (Nasdaq:...fibrillator ( AED ) and diagnostic cardiac monit...llion for the third quarter ended September 30, 20...y also recorded a charge of $18.5 million for an A...44.0 million to increase its valuation allowance a...
(Date:11/9/2009)...Call/ -- Boston Scientific Corporation (NYSE: BSX...8th annual Global Congress for Minimally Invasive ...in Orlando, Florida. Results from two clinical st...ology/Gynecology products, including pelvic floor ...ems used to treat pelvic floor vaginal wall prolap...
Breaking Medicine Technology:Volcano Corporation Presentation at Canaccord Adams Conference to Be Webcast 2Cardiac Science Announces Third Quarter Results 2Cardiac Science Announces Third Quarter Results 3Cardiac Science Announces Third Quarter Results 4Cardiac Science Announces Third Quarter Results 5Cardiac Science Announces Third Quarter Results 6Cardiac Science Announces Third Quarter Results 7Cardiac Science Announces Third Quarter Results 8Cardiac Science Announces Third Quarter Results 9Cardiac Science Announces Third Quarter Results 10Cardiac Science Announces Third Quarter Results 11Cardiac Science Announces Third Quarter Results 12Cardiac Science Announces Third Quarter Results 13Cardiac Science Announces Third Quarter Results 14Cardiac Science Announces Third Quarter Results 15Cardiac Science Announces Third Quarter Results 16Cardiac Science Announces Third Quarter Results 17Cardiac Science Announces Third Quarter Results 18Cardiac Science Announces Third Quarter Results 19Cardiac Science Announces Third Quarter Results 20Boston Scientific's Urology/Gynecology Products Featured in Studies at Global Congress 2Boston Scientific's Urology/Gynecology Products Featured in Studies at Global Congress 3Boston Scientific's Urology/Gynecology Products Featured in Studies at Global Congress 4Boston Scientific's Urology/Gynecology Products Featured in Studies at Global Congress 5New research 3A Consumption of sugar substitutes assists in long term weight control 55125 1New research 3A Consumption of sugar substitutes assists in long term weight control 55125 2When cells run out of fuel 9677 1When cells run out of fuel 9677 2Bioniche Phase III Clinical Trial with Urocidin 28TM 29 Given Continued Green Light by DMC 55122 1Bioniche Phase III Clinical Trial with Urocidin 28TM 29 Given Continued Green Light by DMC 55122 2Bioniche Phase III Clinical Trial with Urocidin 28TM 29 Given Continued Green Light by DMC 55122 3
...07 - Hemispherx Biopharma,Inc. (AMEX: HEB) announ...l of Immunology, April 2007) that explains the uni...rimental therapeutic,Ampligen(R) (Poly I : Poly C...notherapy for Chronic Fatigue Syndrome and as an,a...-reviewed study shows conclusively that the biolog...
...frontera AG announced,that an interim report regar...eratosis was received today from an independent re... investigate the,efficacy and safety of several do...ments received today refer to the clinical results... about the results,after twelve weeks will follow....
Other Medicine Technology:New Report Illuminates Ampligen's Unique Mechanism of Action 2New Report Illuminates Ampligen's Unique Mechanism of Action 3New Report Illuminates Ampligen's Unique Mechanism of Action 4
(Date:11/9/2009)... Businesses of all sizes lookin...for the H1N1 pandemic have a new resource at their... (PRWEB) November 9, 2009 -- Human resource (HR) p...d response efforts for the H1N1 pandemic have a ne...nnesota’s Center for Infectious Disease Rese...
(Date:11/9/2009)... House Delivers on Election Promise. Now Is Time f...wire-USNewswire/ -- The following is a statement b...enerations of struggle and decades of delay, the U...t -- and, to pass historic reform legislation to a... access to high quality, affordable health care. T...
(Date:11/9/2009)...RIVERWOODS, Ill., Nov. 9 The House...ealth Care for America Act , which passed by a vot...tes several significant changes to the tax code an...ely to appear in any Senate version, requiring ext...H has issued a Special Tax Briefing on the tax...
(Date:11/9/2009)...WASHINGTON, Nov. 9 The Churchill...s Award For Leadership to J.W. "Bill" Marriott for...rough progressive free market practices and foster...e. Mr. Marriott will receive his award at a ceremo...ngton D.C. Four Seasons Hotel. ,, "This is a t...
(Date:11/9/2009)...in mice reports success with drugs that inhibit es...ews) -- Two drugs used to treat breast cancer and ...ccording to a new study. , The drugs also clear...and prevented the onset of cancer in mice with pre...vestrant and the breast cancer/osteoporosis drug r...
Breaking Medicine News(10 mins):Health News:New H1N1 Flu Guide Offers Practical Tools and Tips for HR Professionals 2Health News:New H1N1 Flu Guide Offers Practical Tools and Tips for HR Professionals 3Health News:Statement of Anna Burger, Chair, Change to Win, on U.S. House Vote for Health Care Reform 2Health News:CCH Briefing Details Tax Provisions of House Health Care Bill 2Health News:J.W. 'Bill' Marriott to Receive Churchill Centre Award For Leadership 2Health News:Breast Cancer Drugs May Fight Cervical Cancer, Too 2
... disease that can have Complication as its other n...could have, the dreaded would be the foot ulcer, a...n. For diabetics with this dreaded foot ulcer, ... healing of foot ulcers. People with diabetes m...
...are being developed on a daily basis. One of these...nt of those suffering from a degenerative eye cond...sels to grow underneath the retina and leak fluid,...of damaging the retinal tissue. This is a two-s...
...l companies hope to strike a pot of gold by making... war that is likely to escalate in coming days. ...panies to develop anti-AIDS drugs and market it in... entry of four more pharmaceutical companies inclu...
...ing the worst forms of nightmare over the past 3 w... but the threat of malaria . Malaria , not a ... tribal areas of Munger, 200 km (125 miles) southe...id the state's health minister Mr.Shakuni Choudhar...
... the recent issue of the American Journal of Epide...elp protect against a hip fracture. According to D...al, Glostrup, Denmark, and colleagues, when people... hip fractures. In the study, they found tha...
...ministration (FDA) at a conference in Washington, ...ts kind that directly removes the sign of a protei...eatment for chronic myelogenous leukemia (CML). ...rectly cause the disease. Gleevec, was discover...
Other Medicine News:
Nova Epi-fluorescence
...are the hallmark of these stereozoom fluorescent m...n mind. The top (incident) circular 9W fluorescent...inating shadows while remaining cool to the touch....e with 10x to 44x zoom magnification or high-power...
...vative and efficient inverted routine microscope. ...cility. Improved mechanics and increased stability...cular and TS100-F trinocular models. The TS100-F t...ts Nikon's FX-III series photomicrographic systems...
...system utilizes an evanescent wave to excite singl...e coverglass. Extendable "stratum structure". This...th TIRF and epi-fluorescence illumination systems,...ies. It also allows their dedicated filters to be ...
Medicine Products: